Literature DB >> 14867980

The liver and estrogen metabolism; report of cases.

R S LONG, E E SIMMONS.   

Abstract

Keywords:  ESTROGENS/metabolism; LIVER/diseases

Mesh:

Substances:

Year:  1951        PMID: 14867980     DOI: 10.1001/archinte.1951.03810120063006

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN: 0888-2479


× No keyword cloud information.
  6 in total

1.  Congenital cirrhosis of the liver with kernicterus; report of two cases in siblings with a discussion of the relationship to so-called neonatal hepatitis and to iso-immunization disease.

Authors:  J C EHRLICH; I M RATNER
Journal:  Am J Pathol       Date:  1955 Nov-Dec       Impact factor: 4.307

2.  [Role of the liver in excretion and decompositions of adrenocortical hormones].

Authors:  K W BRUCKEL; H J HUBENER; G MEYERHEIM; G LIERSCH
Journal:  Klin Wochenschr       Date:  1954-01-01

3.  [Animal experiments testing a new total liver extract].

Authors:  M BURRI
Journal:  Experientia       Date:  1953-10-15

4.  Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma.

Authors:  Chenglin Lu; Ji Miao; Minhuan Li; Qisi Zheng; Feng Xu; Yiming Pan; Yizhou Wang; Zhi Yang; Xuefeng Xia; Hao Zhu; Jie Chen; Shanhua Bao
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

5.  Inflammatory regulation of steroid sulfatase: A novel mechanism to control estrogen homeostasis and inflammation in chronic liver disease.

Authors:  Mengxi Jiang; Marcus Klein; Ulrich M Zanger; Mohammad K Mohammad; Matthew C Cave; Nilesh W Gaikwad; Natasha J Dias; Kyle W Selcer; Yan Guo; Jinhan He; Xiuhui Zhang; Qiujin Shen; Wenxin Qin; Jiang Li; Song Li; Wen Xie
Journal:  J Hepatol       Date:  2015-07-26       Impact factor: 25.083

6.  ON BILHARZIASIS AND MALE BREAST CANCER IN EGYPT: A PRELIMINARY REPORT AND REVIEW OF THE LITERATURE.

Authors:  M M EL-GAZAYERLI; A S ABDEL-AZIZ
Journal:  Br J Cancer       Date:  1963-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.